Results 161 to 170 of about 114,562 (341)
ChemSusChem, EarlyView.Microbial electrosynthesis (MES) from CO2 by acetogens enables the production of value‐added chemicals. However, its current limitations include O2 stress and insufficient H2 availability. Using Clostridium ljungdahlii as a model in 1‐L electrobioreactors providing high process control, MES is boosted to unprecedent acetate concentrations and rates ...
Anne Kuchenbuch +6 more
wiley +1 more source
46. Placenta Retained One Hundred and Twenty-Three Days after Miscarriage [PDF]
P. W. P. JAGO
openalex +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
O-132. Computerized thromboelastographic parameters amongst women with recurrent miscarriage—evidence for a pro-thrombotic state [PDF]
, 1999 Raj Rai +3 more
openalex +1 more source
FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran +10 more
wiley +1 more source
Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study
ESC Heart Failure, EarlyView.Abstract Aims Inflammation is postulated to be a key pathogenic mechanism in heart failure with preserved ejection fraction (HFpEF). Soluble urokinase plasminogen activator receptor (suPAR), a regulator of innate immune activity, is associated with incident heart failure; however, its role in HFpEF remains unclear.
Christina G. Hutten +9 more
wiley +1 more source
Age‐related penetrance of phospholamban p.Arg14del cardiomyopathy
European Journal of Heart Failure, EarlyView.Age‐related penetrance of phospholamban (PLN) p.Arg14del cardiomyopathy. ECG, electrocardiogram; ICD, implantable cardioverter‐defibrillator; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging; PVC, premature ventricular contraction; SCD, sudden cardiac death; VF, ventricular fibrillation; VT,
Tom E. Verstraelen +22 more
wiley +1 more source